3h лиганды гамка рецептора

3h лиганды гамка рецептора

1. Olsen R.W., Sieghart W. International Union of Pharmacology. LXX. Subtypes of y-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update // Pharmacol Rev. 2008. V. 60. P. 243-260.

2. Hulo N., Bairoch A., Bulliard V., Cerutti L., Cuche B.A., de C.E., Lachaize

3. C., Langendijk-Genevaux P.S., Sigrist С J. The 20 years of PROSITE // Nucleic Acids Res. 2008. V. 36. P. D245-D249.

4. Nayeem N., Green T.P., Martin I.L., Barnard E.A. Quaternary structure of the native GABAa receptor determined by electron microscopic image analysis //J Neurochem. 1994. V. 62. P. 815-818.

5. Chen L., Wang H., Vicini S., Olsen R.W. The y-aminobutyric acid type A (GABAa) receptor-associated protein (GABARAP) promotes GABAa receptor clustering and modulates the channel kinetics // Proc Natl Acad Sci USA. 2000. V. 97. P. 11557-11562.

6. Chebib M. GAB Ac receptor ion channels // Clin Exp Pharmacol Physiol. 2004. V.31.P. 800-804.

7. Chebib M., Johnston G.A. GABA-Activated ligand gated ion channels: medicinal chemistry and molecular biology // J Med Chem. 2000. V. 43. P. 1427-1447.

8. Nusser Z., Sieghart W., Somogyi P. Segregation of different GABAa receptors to synaptic and extrasynaptic membranes of cerebellar granule cells//J Neurosci. 1998. V. 18. P. 1693-1703.

9. Leung C.K.S., Yeung C.K., Chiang S.W.Y., Chan K.P., Pang C.P., Lam

10. D.S.C. GABAa and GABAC (GABAA0r) Receptors Affect Ocular Growth and Form-Deprivation Myopia // Cutaneous and Ocular Toxicology. 2005. V. 24. P. 187-196.

11. Korpi E.R., Sinkkonen S.T. GABA(A) receptor subtypes as targets for neuropsychiatric drug development // Pharmacol Ther. 2006. V. 109. P. 1232.

12. Takanaga H., Ohtsuki S., Hosoya K., Terasaki T. GAT2/BGT-1 as a system responsible for the transport of y-aminobutyric acid at the mouse blood-brain barrier // J Cereb Blood Flow Metab. 2001. V. 21. P. 1232-1239.

13. Chebib M., Vandenberg R.J., Johnston G.A. Analogues of y-aminobutyric acid (GABA) and trans-4-aminocrotonic acid (TACA) substituted in the 2 position as GABAc receptor antagonists // Br J Pharmacol. 1997. V. 122. P. 1551-1560.

14. Serra M., Sanna E., Foddi C., Concas A., Biggio G. Failure of y-hydroxybutyrate to alter the function of the GABAa receptor complex in the rat cerebral cortex // Psychopharmacology (Berl). 1991. V. 104. P. 351-355.

15. Allan R.D., Dickenson H.W., Johnston G.A., Kazlauskas R., Mewett K.N. Structural analogues of ZAPA as GABAa agonists // Neurochem Int. 1997. V.30. P. 583-591.

16. Paula-Lima A.C., De Felice F.G., Brito-Moreira J., Ferreira S.T. Activation of GABA(A) receptors by taurine and muscimol blocks the neurotoxicity of j3-amyloid in rat hippocampal and cortical neurons // Neuropharmacology. 2005. V. 49. P. 1140-1148.

17. Nadeson R., Guo Z., Porter V., Gent J.P., Goodchild C.S. y-Aminobutyric acidA receptors and spinally mediated antinociception in rats // J Pharmacol Exp Ther. 1996. V. 278. P. 620-626.

18. Krogsgaard-Larsen P., Hjeds H., Curtis D.R., Lodge D., Johnston G.A. Dihydromuscimol, thiomuscimol and related heterocyclic compounds as GABA analogues // J Neurochem. 1979. V. 32. P. 1717-1724.

19. Krogsgaard-Larsen P., Johnston G.A., Lodge D., Curtis D.R. A new class of GABA agonist // Nature. 1977. V. 268. P. 53-55.

20. Wafford K.A., Ebert B. Gaboxadol a new awakening in sleep // Curr Opin Pharmacol. 2006. V. 6. P. 30-36.

21. Smith M., Lindquist C.E., Birnir B. Evidence for inhibitory effect of the agonist gaboxadol at human a 1 p 2 y 2S GABAa receptors // Eur J Pharmacol. 2003. V. 478. P. 21-26.

22. Krogsgaard-Larsen P., Frolund B., Liljefors T., Ebert B. GABA(A) agonists and partial agonists: THIP (Gaboxadol) as a non-opioid analgesic and a novel type of hypnotic // Biochem Pharmacol. 2004. V. 68. P. 1573-1580.

23. Johnston G.A. GABAa receptor pharmacology // Pharmacol Ther. 1996. V. 69. P. 173-198.

24. Krogsgaard-Larsen P., Johnston G.A. Structure-activity studies on the inhibition of GABA binding to rat brain membranes by muscimol and related compounds //J Neurochem. 1978. V. 30. P. 1377-1382.

25. Nordmann R., Graff P., Maurer R., Gahwiler B.H. Synthesis and pharmacological evaluation of cis-2,3,3a,4,5,6,7,7a-octahydro-3-oxoisoxazolo5,4-c.pyridine: a structural analogue of the GABA agonist TfflP//J Med Chem. 1985. V. 28. P. 1109-1111.

26. Allan R.D., Dickenson H.W., Fong J. Structure-activity studies on the activity of a series of cyclopentane GABA analogues on GABAa receptors and GABA uptake // Eur J Pharmacol. 1986. V. 122. P. 339-348.

27. Kusama T., Spivak C.E., Whiting P., Dawson V.L., Schaeffer J.C., Uhl G.R. Pharmacology of GABA p 1 and GABA a/(3 receptors expressed in Xenopus oocytes and COS cells // Br J Pharmacol. 1993. V. 109. P. 200-206.

28. Kusama T., Wang T.L., Guggino W.B., Cutting G.R., Uhl G.R. GABA p 2 receptor pharmacological profile: GABA recognition site similarities to p 1 // Eur J Pharmacol. 1993. V. 245. P. 83-84.

29. Rabe H., Picard R., Uusi-Oukari M., Hevers W., Luddens H., Korpi E.R. Coupling between agonist and chloride ionophore sites of the GABA(A) receptor: agonist/antagonist efficacy of 4-PIOL // Eur J Pharmacol. 2000. V. 409. P. 233-242.

30. Ueno S., Bracamontes J., Zorumski C., Weiss D.S., Steinbach J.H. Bicuculline and gabazine are allosteric inhibitors of channel opening of the GABAa receptor // J Neurosci. 1997. V. 17. P. 625-634.

31. Olsen R.W., Ban M., Miller T. Studies on the neuropharmacological activity of bicuculline and related compounds // Brain Res. 1976. V. 102. P. 283299.

32. Frolund B., Tagmose L., Liljefors T., Stensbol T.B., Engblom C., Kristiansen U., Krogsgaard-Larsen P. A novel class of potent 3-isoxazolol GABA(A) antagonists: design, synthesis, and pharmacology // J Med Chem. 2000. V. 43. P. 4930-4933.

33. Mortensen M., Frolund B., Jorgensen A.T., Liljefors T., Krogsgaard-Larsen P., Ebert B. Activity of novel 4-PIOL analogues at human a 1 p 2 y 2S GABA(A) receptors—correlation with hydrophobicity // Eur J Pharmacol. 2002. V. 451. P. 125-132.

34. Heaulme M., Chambon J.P., Leyris R., Wermuth C.G., Biziere K. Characterization of the binding of 3H.SR 95531, a GABAa antagonist, to rat brain membranes // J Neurochem. 1987. V. 48. P. 1677-1686.

35. Beato M., Burzomato V., Sivilotti L.G. The kinetics of inhibition of rat recombinant heteromeric al|3 glycine receptors by the low-affinity antagonist SR-95531 //J Physiol. 2007. V. 580. P. 171-179.

36. Allan R.D., Apostopoulos C., Richardson J.A. 2-Imino-l,3,4-thiadiazole Derivatives of GABA as GABAa Antagonists // Aust J Chem. 1990. V. 43. P. 1767-1772.

37. Melikian A., Schlewer G., Chambon J.P., Wermuth C.G. Condensation of muscimol or thiomuscimol with aminopyridazines yields GABA-A antagonists // J Med Chem. 1992. V. 35. P. 4092-4097.

38. Eghbali M., Curmi J.P., Birnir B., Gage P.W. Hippocampal GABA(A) channel conductance increased by diazepam // Nature. 1997. V. 388. P. 7175.

39. Qinmi Wang, Yifan Han, Hong Xue. Ligands of the GABAA Receptor Benzodiazepine Binding Site // CNS Drug Reviews. 1999. V. 5. P. 125-144.

40. Korpi E.R., Grunder G., Luddens H. Drug interactions at GABA(A) receptors // Prog Neurobiol. 2002. V. 67. P. 113-159.

41. D'Hulst C., Atack J.R., Kooy R.F. The complexity of the GABAa receptor shapes unique pharmacological profiles // Drug Discov Today. 2009. V. 14. P. 866-875.

42. Rudolph U., Mohler H. GABA-based therapeutic approaches: GABAa receptor subtype functions // Curr Opin Pharmacol. 2006. V. 6. P. 18-23.

43. Zhang P., Zhang W., Liu R., Harris B., Skolnick P., Cook J.M. Synthesis of novel imidazobenzodiazepines as probes of the pharmacophore for "diazepam-insensitive" GABAa receptors // J Med Chem. 1995. V. 38. P. 1679-1688.

44. Liu R., Hu R.J., Zhang P., Skolnick P., Cook J.M. Synthesis and pharmacological properties of novel 8-substituted imidazobenzodiazepines: high-affinity, selective probes for a5-containing GABAa receptors // J Med Chem. 1996. V. 39. P. 1928-1934.

45. Kucken A.M., Wagner D.A., Ward P.R., Teissere J.A., Boileau A.J., Czajkowski C. Identification of benzodiazepine binding site residues in the 72 subunit of the y-aminobutyric acid(A) receptor // Mol Pharmacol. 2000. V. 57. P. 932-939.

46. Skolnick P., Hu R.J., Cook C.M., Hurt S.D., Trometer J.D., Liu R., Huang Q., Cook J.M. 3H.RY 80: A high-affinity, selective ligand for y-aminobutyric acidA receptors containing a5 subunits // J Pharmacol Exp Ther. 1997. V. 283. P. 488-493.

47. Lawson J.A., Uyeno E.T., Nienow J., Loew G.H., Toll L. Structure-activity studies of p-carboline analogs // Life Sci. 1984. V. 34. P. 2007-2013.

48. Medina J.H., Viola H., Wolfman C., Marder M., Wasowski C., Calvo D., Paladini A.C. Overview—flavonoids: a new family of benzodiazepine receptor ligands // Neurochem Res. 1997. V. 22. P. 419-425.

49. Hanrahan J.R., Chebib M., Davucheron N.L., Hall B.J., Johnston G.A. Semisynthetic preparation of amentoflavone: A negative modulator at GABA(A) receptors // Bioorg Med Chem Lett. 2003. V. 13. P. 2281-2284.

50. Hansen R.S., Paulsen I., Davies M. Determinants of amentoflavone interaction at the GABA(A) receptor // Eur J Pharmacol. 2005. V. 519. P. 199-207.

51. Wang F., Xu Z., Ren L., Tsang S.Y., Xue H. GABA A receptor subtype selectivity underlying selective anxiolytic effect of baicalin // Neuropharmacology. 2008. V. 55. P. 1231-1237.

52. Kawadias D., Monschein V., Sand P., Riederer P., Schreier P. Constituents of sage (Salvia officinalis) with in vitro affinity to human brain benzodiazepine receptor // Planta Med. 2003. V. 69. P. 113-117.

53. Wasowski C., Marder M., Viola H., Medina J.H., Paladini A.C. Isolation and identification of 6-methylapigenin, a competitive ligand for the brain GABA(A) receptors, from Valeriana wallichii // Planta Med. 2002. V. 68. P. 934-936.

54. Kueny-Stotz M., Chassaing S., Brouillard R., Nielsen M., Goeldner M. Flavylium salts as in vitro precursors of potent ligands to brain GABA-A receptors // Bioorg Med Chem Lett. 2008. V. 18. P. 4864-4867.

55. Jones M.V., Harrison N.L., Pritchett D.B., Hales T.G. Modulation of the GABAa receptor by propofol is independent of the y subunit // J Pharmacol Exp Ther. 1995. V. 274. P. 962-968.

56. Stewart D., Desai R., Cheng Q., Liu A., Forman S.A. Tryptophan mutations at azi-etomidate photo-incorporation sites on al or (32 subunits enhance GABAa receptor gating and reduce etomidate modulation // Mol Pharmacol. 2008. V. 74. P. 1687-1695.

57. Gaul S., Ozsarac N., Liu L., Fink R.H., Gage P.W. The neuroactive steroids axalone and pregnanolone increase the conductance of single GABAa channels in newborn rat hippocampal neurons // J Steroid Biochem Mol Biol. 2007. V. 104. P. 35-44.

58. Granger R.E., Campbell E.L., Johnston G.A. (+)- And (-)-borneol: efficacious positive modulators of GABA action at human recombinant CI1P2Y2L GABA(A) receptors // Biochem Pharmacol. 2005. V. 69. P. 11011111.

59. Hall A.C., Turcotte C.M., Betts B.A., Yeung W.Y., Agyeman A.S., Burk L.A. Modulation of human GABAa and glycine receptor currents by menthol and related monoterpenoids // Eur J Pharmacol. 2004. V. 506. P. 916.

60. Hold K.M., Sirisoma N.S., Ikeda T., Narahashi T., Casida J.E. A-thujone (the active component of absinthe): y-aminobutyric acid type A receptor modulation and metabolic detoxification // Proc Natl Acad Sci USA. 2000. V. 97. P. 3826-3831.

61. Garcia D.A., Bujons J., Vale C., Sunol C. Allosteric positive interaction of thymol with the GABAa receptor in primary cultures of mouse cortical neurons //Neuropharmacology. 2006. V. 50. P. 25-35.

62. Hossain S.J., Hamamoto K., Aoshima H., Hara Y. Effects of tea components on the response of GABA(A) receptors expressed in Xenopus Oocytes // J Agric Food Chem. 2002. V. 50. P. 3954-3960.

63. Hossain S.J., Aoshima H., Koda H., Kiso Y. Effects of coffee components on the response of GABA(A) receptors expressed in Xenopus oocytes // J Agric Food Chem. 2003. V. 51. P. 7568-7575.

64. Halbsguth C., Meissner O., Haberlein H. Positive cooperation of protoberberine type 2 alkaloids from Corydalis cava on the GABA(A) binding site // Planta Med. 2003. V. 69. P. 305-309.

65. Yi P.L., Tsai C.H., Chen Y.C., Chang F.C. r-aminobutyric acid (GABA) receptor mediates suanzaorentang, a traditional Chinese herb remedy, -induced sleep alteration // J Biomed Sci. 2007. V. 14. P. 285-297.

66. Ye J.H., Liu P.L., Wu W.H., McArdle JJ. Cocaine depresses GABAa current of hippocampal neurons // Brain Res. 1997. V. 770. P. 169-175.

67. Ye J.H., Hunt T., Wu W.H., McArdle JJ. Ondansetron modulates GABA(A) current of rat central nervous system neurons // Eur J Pharmacol. 1997. V. 337. P. 87-94.

68. Li C.Y., Wang H., Xue H., Carlier P.R., Hui K.M., Pang Y.P., Li Z.W., Han Y.F. Bis(7)-tacrine, a novel dimeric AChE inhibitor, is a potent GABA(A) receptor antagonist//Neuroreport. 1999. V. 10. P. 795-800.

69. Squires R.F., Saederup E. Clozapine and several other antipsychotic/antidepressant drugs preferentially block the same 'core' fraction of GABA(A) receptors // Neurochem Res. 1998. V. 23. P. 12831290.

70. Mascia M.P., Bachis E., Obili N., Maciocco E., Cocco G.A., Sechi G.P., Biggio G. Thiocolchicoside inhibits the activity of various subtypes of recombinant GABA(A) receptors expressed in Xenopus laevis oocytes // Eur J Pharmacol. 2007. V. 558. P. 37-42.

71. Fisher J.L. Amiloride inhibition of y-aminobutyric acid(A) receptors depends upon the a subunit subtype // Mol Pharmacol. 2002. V. 61. P. 13221328.

72. Green M.A., Halliwell R.F. Selective antagonism of the GABA(A) receptor by ciprofloxacin and biphenylacetic acid // Br J Pharmacol. 1997. V. 122. P. 584-590.

73. Feng H.J., Botzolakis E.J., Macdonald R.L. Context-dependent modulation of aj3y and ap5 GABAa receptors by penicillin: implications for phasic and tonic inhibition//Neuropharmacology. 2009. V. 56. P. 161-173.

74. Simeone T.A., Otto J.F., Wilcox K.S., White H.S. Felbamate is a subunit selective modulator of recombinant y-aminobutyric acid type A receptors expressed in Xenopus oocytes // Eur J Pharmacol. 2006. V. 552. P. 31-35.

75. Simeone T.A., Wilcox K.S., White H.S. Subunit selectivity of topiramate modulation of heteromeric GABA(A) receptors // Neuropharmacology. 2006. V. 50. P. 845-857.

76. He Y., Benz A., Fu T., Wang M., Covey D.F., Zorumski C.F., Mennerick S. Neuroprotective agent riluzole potentiates postsynaptic GABA(A) receptor function//Neuropharmacology. 2002. V. 42. P. 199-209.

77. Robinson R.T., Drafts B.C., Fisher J.L. Fluoxetine increases GABA(A) receptor activity through a novel modulatory site // J Pharmacol Exp Ther. 2003. V. 304. P. 978-984.

78. Brejc K., van Dijk W.J., Klaassen R.V., Schuurmans M., van Der O.J., Smit A.B., Sixma T.K. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors // Nature. 2001. V. 411. P. 269276.

79. Cromer B.A., Morton C.J., Parker M.W. Anxiety over GABA(A) receptor structure relieved by AChBP // Trends Biochem Sci. 2002. V. 27. P. 280287.

80. Dougherty D.A. Cys-loop neuroreceptors: structure to the rescue? // Chem Rev. 2008. V. 108. P. 1642-1653.

81. Sigel E., Schaerer M.T., Buhr A., Baur R. The benzodiazepine binding pocket of recombinant (XiP2y2 y-aminobutyric acidA receptors: relativeorientation of ligands and amino acid side chains // Mol Pharmacol. 1998. V. 54. P. 1097-1105.

82. Ernst M., Brauchart D., Boresch S., Sieghart W. Comparative modeling of GABA(A) receptors: limits, insights, future developments // Neuroscience. 2003. V. 119. P. 933-943.

83. Ernst M., Bruckner S., Boresch S., Sieghart W. Comparative models of GABAa receptor extracellular and transmembrane domains: important insights in pharmacology and function // Mol Pharmacol. 2005. V. 68. P. 1291-1300.

84. Padgett C.L., Hanek A.P., Lester H.A., Dougherty D.A., Lummis S.C. Unnatural amino acid mutagenesis of the GABA(A) receptor binding site residues reveals a novel cation-pi interaction between GABA and p2Tyr97 // J Neurosci. 2007. V. 27. P. 886-892.

85. Mokrab Y., Bavro V.N., Mizuguchi K., Todorov N.P., Martin I.L., Dunn S.M., Chan S.L., Chau P.L. Exploring ligand recognition and ion flow in comparative models of the human GABA type A receptor // J Mol Graph Model. 2007. V. 26. P. 760-774.

86. Trudell J.R., Bertaccini E. Molecular modelling of specific and non-specific anaesthetic interactions // Br J Anaesth. 2002. V. 89. P. 32-40.

87. Campagna-Slater V., Weaver D.F. Molecular modelling of the GABAa ion channel protein // J Mol Graph Model. 2007. V. 25. P. 721-730.

88. O'Mara M., Cromer B., Parker M., Chung S.H. Homology model of the GABAa receptor examined using Brownian dynamics // Biophys J. 2005. V. 88. P. 3286-3299.

89. Sedelnikova A., Smith C.D., Zakharkin S.O., Davis D., Weiss D.S., Chang Y. Mapping the pi GABA(C) receptor agonist binding pocket. Constructing a complete model // J Biol Chem. 2005. V. 280. P. 1535-1542.

90. Harrison N.J., Lummis S.C. Molecular modeling of the GABA(C) receptor ligand-binding domain // J Mol Model. 2006. V. 12. P. 317-324.

91. Abdel-Halim H., Hanrahan J.R., Hibbs D.E., Johnston G.A., Chebib M. A molecular basis for agonist and antagonist actions at GABA(C) receptors // Chem Biol Drug Des. 2008. V. 71. P. 306-327.

92. Zacharias N., Dougherty D.A. Cation-pi interactions in ligand recognition and catalysis // Trends Pharmacol Sci. 2002. V. 23. P. 281-287.

93. Celie P.H., van Rossum-Fikkert S.E., van Dijk W.J., Brejc K., Smit A.B., Sixma T.K. Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures // Neuron. 2004. V. 41. P. 907-914.

94. Unwin N. Refined structure of the nicotinic acetylcholine receptor at 4A resolution // J Mol Biol. 2005. V. 346. P. 967-989.

95. Bourne Y., Talley T.T., Hansen S.B., Taylor P., Marchot P. Crystal structure of a Cbtx-AChBP complex reveals essential interactions between snake a-neurotoxins and nicotinic receptors // EMBO J. 2005. V. 24. P. 1512-1522.

96. Hansen S.B., Sulzenbacher G., Huxford T., Marchot P., Taylor P., Bourne Y. Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations // EMBO J. 2005. V. 24. P. 3635-3646.

97. Dellisanti C.D., Yao Y., Stroud J.C., Wang Z.Z., Chen L. Crystal structure of the extracellular domain of nAChR ai bound to a-bungarotoxin at 1.94 A resolution //Nat Neurosci. 2007. V. 10. P. 953-962.

98. Hilf R.J., Dutzler R. X-ray structure of a prokaryotic pentameric ligand-gated ion channel // Nature. 2008. V. 452. P. 375-379.

99. Bocquet N., Nury H., Baaden M., Le P.C., Changeux J.P., Delarue M., Corringer P J. X-ray structure of a pentameric ligand-gated ion channel in an apparently open conformation // Nature. 2009. V. 457. P. 111-114.

100. Miyazawa A., Fujiyoshi Y., Stowell M., Unwin N. Nicotinic acetylcholine receptor at 4.6 A resolution: transverse tunnels in the channel wall // J Mol Biol. 1999. V. 288. P. 765-786.

101. Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., Ferrin T.E. UCSF Chimera a visualization system for139exploratoiy research and analysis // J Comput Chem. 2004. V. 25. P. 16051612.

102. Kabsch W., Sander C. Dictionary of protein secondaiy structure: pattern recognition of hydrogen-bonded and geometrical features // Biopolymers. 1983. V. 22. P. 2577-2637.

103. Dent J.A. Evidence for a diverse Cys-loop ligand-gated ion channel superfamily in early bilateria // J Mol Evol. 2006. V. 62. P. 523-535.

104. Unwin N. Structure and action of the nicotinic acetylcholine receptor explored by electron microscopy // FEBS Lett. 2003. V. 555. P. 91-95.

105. Shao J., Tanner S.W., Thompson N., Cheatham T.E. Clustering Molecular Dynamics Trajectories: 1. Characterizing the Performance of Different Clustering Algorithms // Journal of Chemical Theoiy and Computation. 2007. V. 3.P. 2312-2334.

106. Newell J.G., McDevitt R.A., Czajkowski C. Mutation of glutamate 155 of the GABAa receptor (32 subunit produces a spontaneously open channel: a trigger for channel activation // J Neurosci. 2004. V. 24. P. 11226-11235.

107. Armougom F., Moretti S., Poirot O., Audic S., Dumas P., Schaeli B., Keduas V., Notredame C. Expresso: automatic incorporation of structural information in multiple sequence alignments using 3D-Coffee // Nucleic Acids Res. 2006. V. 34. P. W604-W608.

108. Gasteiger E., Gattiker A., Hoogland C., Ivanyi I., Appel R.D., Bairoch A. ExPASy: The proteomics server for in-depth protein knowledge and analysis //Nucleic Acids Res. 2003. V. 31. P. 3784-3788.

109. Eswar N., Webb B., Marti-Renom M.A., Madhusudhan M.S., Eramian D., Shen M.Y., Pieper U., Sali A. Comparative protein structure modeling using MODELLER // Curr Protoc Protein Sci. 2007. V. Chapter 2. P. Unit.

110. Laskowski R.A., Rullmannn J.A., MacArthur M.W., Kaptein R., Thornton J.M. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR // J Biomol NMR. 1996. V. 8. P. 477-486.

111. Eisenberg D., Luthy R., Bowie J.U. VERIFY3D: assessment of protein models with three-dimensional profiles // Methods Enzymol. 1997. V. 277. P. 396-404.

112. Moustakas D.T., Lang P.T., Pegg S., Pettersen E., Kuntz I.D., Brooijmans N., Rizzo R.C. Development and validation of a modular, extensible docking program: DOCK 5 // J Comput Aided Mol Des. 2006. V. 20. P. 601-619.

113. DeLano, W.L. The PyMOL Molecular Graphics System (2002) DeLano Scientific, Palo Alto, CA, USA. 2010.

114. Holden J.H., Czajkowski C. Different residues in the GABA(A) receptor a lT60-a 1K70 region mediate GABA and SR-95531 actions // J Biol Chem. 2002. V. 277. P. 18785-18792.

115. Boileau A.J., Evers A.R., Davis A.F., Czajkowski C. Mapping the agonist binding site of the GABAa receptor: evidence for a (3-strand // J Neurosci. 1999. V. 19. P. 4847-4854.

116. Baur R., Sigel E. On high- and low-affinity agonist sites in GABAa receptors // J Neurochem. 2003. V. 87. P. 325-332.

117. Kloda J.H., Czajkowski C. Agonist-, antagonist-, and benzodiazepine-induced structural changes in the al Metll3-Leul32 region of the GABAa receptor // Mol Pharmacol. 2007. V. 71. P. 483-493.

118. Newell J.G., Davies M., Bateson A.N., Dunn S.M. Tyrosine 62 of the y-aminobutyric acid type A receptor (3 2 subunit is an important determinant of high affinity agonist binding // J Biol Chem. 2000. V. 275. P. 14198-14204.

119. Boileau A.J., Newell J.G., Czajkowski C. GABA(A) receptor (3 2 Tyr97 and Leu99 line the GABA-binding site. Insights into mechanisms of agonist and antagonist actions // J Biol Chem. 2002. V. 277. P. 2931-2937.

120. Wagner D.A., Czajkowski C. Structure and dynamics of the GABA binding pocket: A narrowing cleft that constricts during activation 11 J Neurosci. 2001. V. 21. P. 67-74.

121. Crowley P.B., Golovin A. Cation-pi interactions in protein-protein interfaces //Proteins. 2005. V. 59. P. 231-239.141

122. Zarrindast M.R., Bakhsha A., Rostami P., Shafaghi B. Effects of intrahippocampal injection of GABAergic drugs on memory retention of passive avoidance learning in rats // J Psychopharmacol. 2002. V. 16. P. 313-319.

123. Zarrindast M.R., Noorbakhshnia M., Motamedi F., Haeri-Rohani A., Rezayof A. Effect of the GABAergic system on memory formation and state-dependent learning induced by morphine in rats // Pharmacology. 2006. V. 76. P. 93-100.

124. Czajkowski C. Neurobiology: triggers for channel opening // Nature. 2005. V. 438. P. 167-168.

125. Paulsen I.M., Martin I.L., Dunn S.M. Isomerization of the proline in the M2-M3 linker is not required for activation of the human 5-HT3A receptor // J Neurochem. 2009. V. 110. P. 870-878.

126. Crestani F., Martin J.R., Mohler H., Rudolph U. Mechanism of action of the hypnotic Zolpidem in vivo // Br J Pharmacol. 2000. V. 131. P. 1251-1254.

127. Berezhnoy D., Nyfeler Y., Gonthier A., Schwob H., Goeldner M., Sigel E. On the benzodiazepine binding pocket in GABAa receptors // J Biol Chem. 2004. V. 279. P. 3160-3168.

128. Amin J., Brooks-Kayal A., Weiss D.S. Two tyrosine residues on the a subunit are crucial for benzodiazepine binding and allosteric modulation of y-aminobutyric acidA receptors // Mol Pharmacol. 1997. V. 51. P. 833-841.

129. Schaerer M.T., Buhr A., Baur R., Sigel E. Amino acid residue 200 on the al subunit of GABA(A) receptors affects the interaction with selected benzodiazepine binding site ligands // Eur J Pharmacol. 1998. V. 354. P. 283-287.

130. Wingrove P.B., Thompson S.A., Wafford K.A., Whiting PJ. Key amino acids in the y subunit of the y-aminobutyric acidA receptor that determine ligand binding and modulation at the benzodiazepine site // Mol Pharmacol. 1997. V. 52. P. 874-881.

131. Leppa E., Vekovischeva O.Y., Linden A.M., Wulff P., Oberto A., Wisden W., Korpi E.R. Agonistic effects of the p-carboline DMCM revealed in GABA(A) receptor y 2 subunit F77I point-mutated mice // Neuropharmacology. 2005. V. 48. P. 469-478.

132. Buhr A., Sigel E. A point mutation in the y2 subunit of y-aminobutyric acid type A receptors results in altered benzodiazepine binding site specificity // Proc Natl Acad Sci USA. 1997. V. 94. P. 8824-8829.

133. Teissere J.A., Czajkowski C. A (P)-strand in the (y)2 subunit lines the benzodiazepine binding site of the GABA A receptor: structural rearrangements detected during channel gating // J Neurosci. 2001. V. 21. P. 4977-4986.

134. Lawson J.A., Uyeno E.T., Nienow J., Loew G.H., Toll L. Structure-activity studies of p-carboline analogs // Life Sci. 1984. V. 34. P. 2007-2013.

135. June H.L., Torres L., Cason C.R., Hwang B.H., Braun M.R., Murphy J.M. The novel benzodiazepine inverse agonist RO19-4603 antagonizes ethanol motivated behaviors: neuropharmacological studies // Brain Res. 1998. V. 784. P. 256-275.

136. Wingrove P.B., Safo P., Wheat L., Thompson S.A., Wafford K.A., Whiting P.J. Mechanism of a.-subunit selectivity of benzodiazepine pharmacology at [y]-aminobutyric acid type A receptors // European Journal of Pharmacology. 2002. V. 437. P. 31-39.

137. Delong R. GABA(A) receptor a5 subunit as a candidate gene for autism and bipolar disorder: a proposed endophenotype with parent-of-origin and gain-of-function features,with or without oculocutaneous albinism // Autism. 2007. V. 11. P. 135-147.

138. Dong C.J., Hare W.A. GABAC feedback pathway modulates the amplitude and kinetics of ERG b-wave in a mammalian retina in vivo // Vision Res. 2002. V. 42. P. 1081-1087.

139. Lummis S.C., Beene L., Harrison N.J., Lester H.A., Dougherty D.A. A cation-pi binding interaction with a tyrosine in the binding site of the GABAc receptor // Chem Biol. 2005. V. 12. P. 993-997.

140. Cramer R.D., Patterson D.E., Bunce J.D. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins // Journal of the American Chemical Society. 1988. V. 110. P. 5959-5967.

141. Klebe G., Abraham U., Mietzner T. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity // J Med Chem. 1994. V. 37. P. 4130-4146.

142. Palyulin V.A., Radchenko E.V., Zefirov N.S. Molecular field Topology analysis method in QSAR studies of organic compounds // J Chem Inf Comput Sci. 2000. V. 40. P. 659-667.

143. SYBYL 7.3, Tripos International, 1699 South Hanley Rd., St. Louis, Missouri, 63144, USA. 2010.

144. Instant JChem 2.1, 2010, ChemAxon fhttp://www.chemaxon.corrQ. 2010.

145. Артеменко H.B., Баскин И.И., Палюлин B.A., Зефиров Н.С. Прогнозирование физических свойств органических соединений при помощи искусственных нейронных сетей в рамках подструктурного подхода. // Докл. РАН. 2001. - Т. 381, № 2. - С. 203-206.

146. Baskin 1.1., Halberstam N. М., Artemenko N. V., Palyulin V. A., Zefirov N. S. // EuroQSAR 2002 Designing Drugs and Crop Protectants: processes, problems and solutions / Eds., M.Ford et al: Blackwell Publishing, 2003. P. 260-263.

147. Жохова Н.И., Баскин И.И., Палюлин B.A., Зефиров А.Н., Зефиров Н.С. Фрагментные дескрипторы с «выделенными» атомами и их применение в исследованиях QSAR/QSPR. // Докл. РАН. 2007. - Т. 417, № 5. - С. 639641.

148. Neural Network. Backprop. URL: http://moonflare.com/code/nnetwork.php.

149. Blum L.C., Reymond J.L. 970 million druglike small molecules for virtual screening in the chemical universe database GDB-13 // J Am Chem Soc. 2009. V. 131. P. 8732-8733.

150. Diversity Set II Information. National Cancer Institute. URL: http://dtp.nci.nih.gov/branches/dscb/div2 explanation.html.

151. Huang N., Shoichet B.K., Irwin J.J. Benchmarking sets for molecular docking // J Med Chem. 2006. V. 49. P. 6789-6801.

152. Uusi-Oukari M., Maksay G. Allosteric modulation of 3H.EBOB binding to GABAa receptors by diflunisal analogues // Neurochem Int. 2006. V. 49. P. 676-682.

153. Irwin J.J., Shoichet B.K. ZINCa free database of commercially available compounds for virtual screening // J Chem Inf Model. 2005. V. 45. P. 177-182.

154. Lipinski C.A., Lombardo F., Dominy B.W., Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings // Adv Drug Deliv Rev. 2001. V. 46. P. 326.

155. Voigt J.H., Bienfait B., Wang S., Nicklaus M.C. Comparison of the NCI open database with seven large chemical structural databases // J Chem Inf Comput Sci. 2001. V. 41. P. 702-712.

156. Guha R., Howard M.T., Hutchison G.R., Murray-Rust P., Rzepa H., Steinbeck C., Wegner J., Willighagen E.L. The Blue Obelisk-interoperability in chemical informatics // J Chem Inf Model. 2006. V. 46. P. 991-998.

157. Melnikov A.A., Palyulin V.A., Zefirov N.S. Generation of molecular graphs for QSAR studies: an approach based on supergraphs // J Chem Inf Model. 2007. V. 47. P. 2077-2088.

158. Ulens C., Hogg R.C., Celie P.H., Bertrand D., Tsetlin V., Smit A.B., Sixma T.K. Structural determinants of selective a-conotoxin binding to a nicotinic acetylcholine receptor homolog AChBP // Proc Natl Acad Sci USA. 2006. V. 103. P. 3615-3620.

159. Hansen S.B., Taylor P. Galanthamine and non-competitive inhibitor binding to ACh-binding protein: evidence for a binding site on non-a-subunit interfaces of heteromeric neuronal nicotinic receptors // J Mol Biol. 2007. V. 369. P. 895901.

160. Hilf R.J., Dutzler R. Structure of a potentially open state of a proton-activated pentameric ligand-gated ion channel //Nature. 2009. V. 457. P. 115-118.

161. Hansen S.B., Wang H.L., Taylor P., Sine S.M. An ion selectivity filter in the extracellular domain of Cys-loop receptors reveals determinants for ion conductance // J Biol Chem. 2008. V. 283. P. 36066-36070.

3h лиганды гамка рецептора

3h лиганды гамка рецептора

3h лиганды гамка рецептора

3h лиганды гамка рецептора

3h лиганды гамка рецептора

3h лиганды гамка рецептора

Похожие новости: